Cargando…

Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies

INTRODUCTION: Colorectal cancer is one of the leading causes of cancer-related morbidity worldwide and it has been reported to be associated with poor lifestyle habits which include excess tobacco and alcohol intake as well as genetics and age factors. Probiotics such as the lactic acid bacteria and...

Descripción completa

Detalles Bibliográficos
Autores principales: Dikeocha, Ifeoma Julieth, Al-Kabsi, Abdelkodose Mohammed, Hussin, Salasawati, Alshawsh, Mohammed Abdullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418674/
https://www.ncbi.nlm.nih.gov/pubmed/32771989
http://dx.doi.org/10.1136/bmjopen-2020-038128
_version_ 1783569736226832384
author Dikeocha, Ifeoma Julieth
Al-Kabsi, Abdelkodose Mohammed
Hussin, Salasawati
Alshawsh, Mohammed Abdullah
author_facet Dikeocha, Ifeoma Julieth
Al-Kabsi, Abdelkodose Mohammed
Hussin, Salasawati
Alshawsh, Mohammed Abdullah
author_sort Dikeocha, Ifeoma Julieth
collection PubMed
description INTRODUCTION: Colorectal cancer is one of the leading causes of cancer-related morbidity worldwide and it has been reported to be associated with poor lifestyle habits which include excess tobacco and alcohol intake as well as genetics and age factors. Probiotics such as the lactic acid bacteria and Bifidobacterium as well as probiotic containing foods (kombucha, kefir, miso etc) have received lots of attention as anticancer agents for prevention and treatment. The effects of the administration of probiotics to patients with colorectal cancer is the primary goal of this systematic review. The overall aim is to assess how the use of probiotics in patients with colorectal cancer helps in the management of colorectal cancer and its effect on the diversity of gut microbiota. The final systematic review will provide a comprehensive evidence base for the use and efficacy of probiotics in patient with colorectal cancer care. METHODS AND ANALYSIS: The systematic review, will be conducted by extensively searching different databases such as PubMed, Web of Science, Scopus, Wiley and ProQuest to identify randomised controlled trials (with no time frame) which relate to the administration of probiotics to patients with colorectal cancer. The search strategy will include words like colorectal cancer, probiotics, Bifidobacterium, clinical trials etc. A systematic search of databases was performed between 17 and 20 January 2020. Two reviewers will independently review the studies and also search the reference lists of the eligible studies to obtain more references. Data will be extracted from the eligible studies using standardised data extraction form. After assessing the risk of bias, qualitative analysis will be used to synthesise the systematic review. ETHICS AND DISSEMINATION: This is a protocol for a systematic review; therefore, it doesn’t require any ethics approval. We intend to disseminate the protocol in a peer reviewed journal.
format Online
Article
Text
id pubmed-7418674
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-74186742020-08-18 Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies Dikeocha, Ifeoma Julieth Al-Kabsi, Abdelkodose Mohammed Hussin, Salasawati Alshawsh, Mohammed Abdullah BMJ Open Oncology INTRODUCTION: Colorectal cancer is one of the leading causes of cancer-related morbidity worldwide and it has been reported to be associated with poor lifestyle habits which include excess tobacco and alcohol intake as well as genetics and age factors. Probiotics such as the lactic acid bacteria and Bifidobacterium as well as probiotic containing foods (kombucha, kefir, miso etc) have received lots of attention as anticancer agents for prevention and treatment. The effects of the administration of probiotics to patients with colorectal cancer is the primary goal of this systematic review. The overall aim is to assess how the use of probiotics in patients with colorectal cancer helps in the management of colorectal cancer and its effect on the diversity of gut microbiota. The final systematic review will provide a comprehensive evidence base for the use and efficacy of probiotics in patient with colorectal cancer care. METHODS AND ANALYSIS: The systematic review, will be conducted by extensively searching different databases such as PubMed, Web of Science, Scopus, Wiley and ProQuest to identify randomised controlled trials (with no time frame) which relate to the administration of probiotics to patients with colorectal cancer. The search strategy will include words like colorectal cancer, probiotics, Bifidobacterium, clinical trials etc. A systematic search of databases was performed between 17 and 20 January 2020. Two reviewers will independently review the studies and also search the reference lists of the eligible studies to obtain more references. Data will be extracted from the eligible studies using standardised data extraction form. After assessing the risk of bias, qualitative analysis will be used to synthesise the systematic review. ETHICS AND DISSEMINATION: This is a protocol for a systematic review; therefore, it doesn’t require any ethics approval. We intend to disseminate the protocol in a peer reviewed journal. BMJ Publishing Group 2020-08-07 /pmc/articles/PMC7418674/ /pubmed/32771989 http://dx.doi.org/10.1136/bmjopen-2020-038128 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Oncology
Dikeocha, Ifeoma Julieth
Al-Kabsi, Abdelkodose Mohammed
Hussin, Salasawati
Alshawsh, Mohammed Abdullah
Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies
title Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies
title_full Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies
title_fullStr Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies
title_full_unstemmed Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies
title_short Role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies
title_sort role of probiotics in patients with colorectal cancer: a systematic review protocol of randomised controlled trial studies
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418674/
https://www.ncbi.nlm.nih.gov/pubmed/32771989
http://dx.doi.org/10.1136/bmjopen-2020-038128
work_keys_str_mv AT dikeochaifeomajulieth roleofprobioticsinpatientswithcolorectalcancerasystematicreviewprotocolofrandomisedcontrolledtrialstudies
AT alkabsiabdelkodosemohammed roleofprobioticsinpatientswithcolorectalcancerasystematicreviewprotocolofrandomisedcontrolledtrialstudies
AT hussinsalasawati roleofprobioticsinpatientswithcolorectalcancerasystematicreviewprotocolofrandomisedcontrolledtrialstudies
AT alshawshmohammedabdullah roleofprobioticsinpatientswithcolorectalcancerasystematicreviewprotocolofrandomisedcontrolledtrialstudies